PKS Advisory Services, LLC

SEC CIK: 0001605401
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by PKS Advisory Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overview All 13F holders of ADAPY Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of ADAPY by PKS Advisory Services, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−17,000−100.0%	Sold out	Holders
Q2 2025	17,000	$4.08K	<0.1%	+17,000	New	Holders
Q1 2025	0	$0	0.0%	−17,000−100.0%	Sold out	Holders
Q4 2024	17,000	$9.16K	<0.1%	–	No prior filing	Holders